BTIG Is 'Generally Skeptical' On Kite Pharma Expectations
August 31, 2016 at 09:17 AM EDT
BTIG has started coverage of Kite Pharma Inc (NASDAQ: KITE) with a Neutral rating, as it is skeptical over current investor expectations ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.